From natural disasters to an opioid epidemic that prompted a public health emergency declaration, science was at the forefront of events that shaped our nation in 2017. National public opinion surveys commissioned by Research!America throughout the year revealed that a majority of Americans agree that public and private sector research is critical to better health, economic growth, global competitiveness and more. While the perception of science and scientists is positive, based on survey findings, scientists and our nation’s scientific enterprise remain largely invisible to the public. The public overwhelmingly (82%) considers scientists trustworthy spokespersons for science, far above...
Research!America’s webinars in 2017 tackled a variety of timely health and policy issues, such as the nation’s opioid crisis which accounts for six out of 10 drug overdose deaths, the vital role of federally supported global health research, and the importance of effective communication in educating the public and lawmakers about the far-reaching benefits of public and private sector research. Scientists, students, advocates, influencers, decision-makers and media participated in the webinars, which provided relevant and detailed information to raise awareness and inform advocacy initiatives. On December 4, Research!America and the Society for Neuroscience hosted the webinar “Leveraging...
Dear Research Advocate: In considering resolutions for the coming year, I am reminded that resolution connotes action . I am optimistic that 2018 will be a year of action, a year in which research and innovation amp up our economy, even as they lead to better health and quality of life. Congress will respond to advocates if we all take action and amp up our efforts — it’s an election year, after all! Love it or loathe it, tax reform has set the stage for additional action to drive the economy. In addition to passing a bipartisan budget deal that lifts spending caps for both defense and non-defense discretionary funding, and repealing or suspending the medical device tax, Congress and the...
Research into the development of Ebola vaccines, efforts to address opioid use among women, infectious diseases and a record number of novel drug approvals are among the many examples of federal health agencies making tremendous strides in 2017 to address complex and deadly health threats. The agencies highlighted their achievements in year-end articles, videos and reports on their websites. The National Institutes of Health (NIH) described progress with two Ebola vaccines and a bionic pancreas to better treat type 1 diabetes in addition to other clinical advances. The NIH also supported the work of three recipients of the Nobel Prize in Physiology or Medicine and one recipient of the Nobel...
As 2017 comes to a close, we’d like to highlight the year’s 10 most popular guest blog posts (based on page views), which provided compelling insights and information on a variety of topics including public health, oral health, clinical research and advocacy. We extend a big thank you to this year’s many outstanding contributors – students, researchers, industry experts, public health professionals, patient advocates – who are committed to combating our nation’s most pressing health challenges. 1) Dental Hygienists: Connectors of Oral Health to General Health October 27 : In our most-read guest post of the year, the American Dental Education Association’s Kim T. Isringhausen discussed the...
Dear Research Advocate: Last weekend, many of us awoke to reports that CDC officials were barred from using several words and phrases, among them “science-based,” “evidence-based” and “diversity.” CDC and HHS officials quickly released statements contradicting the reports. Now there are more reports of efforts to replace certain words in agency budget documents. While every Administration has favored programs and favored vocabulary, this bears watching. As AAAS CEO and Research!America board member Dr. Rush Holt, explained on CNN , this is emblematic of a larger issue facing our nation: “neglect of evidence.” See our statement and a sign-on letter spearheaded by APHA to HHS Acting Secretary...
Dear Research Advocate: This week marks the one year anniversary of the signing of the 21st Century Cures Act. Ominously, momentum to accomplish the goals of this ground-breaking, bipartisan legislation and so much more could be forced off track by events of the last few hours: release by House leadership of a “hybrid” continuing resolution/Department of Defense bill that would fully fund FY18 Defense spending ($640B) while flat- funding everything else until (at least) January 19. The January 19th deadline wasn’t pulled out of thin air; that is the deadline for congressional action to prevent an across-the-board spending cut to meet the FY18 budget caps. The ‘hybrid’ proposal would...
Our nation’s health has improved in some areas but serious health challenges remain related to the escalating drug crisis and disparities in access to care. United Health Foundation’s 2017 America’s Health Rankings report indicates smoking prevalence, the rate of preventable hospitalizations and the percentage of uninsured Americans have declined, but the drug death rate has trended upward. In the past year, drug deaths reached the highest level recorded by America’s Health Rankings , increasing by 7%, particularly among whites. Even states that consistently rank among the healthiest in the nation saw increased mortality rates due to the drug epidemic. Over the past five years, drug death...
The December 2017 newsletter is now online . Highlights from this month include: Experts representing the COPD research continuum discussed the latest developments in research and the prevention and treatment of the disease at a congressional briefing hosted by Research!America titled “From Discovery to Delivery: Research at Work – COPD” on November 15, 2017. Research!America and the Society for Neuroscience hosted a webinar, “Leveraging Public Opinion in Support of Science” on Monday, December 4. The importance of advocating for robust federal investments in basic science to help understand eating disorders, mental health issues and other diseases was the focus of a panel discussion at...
Dear Research Advocate: Today the House and Senate passed a short-term continuing resolution (CR) to flat-fund the government through December 22. Congressional leaders hope this stop-gap will buy them enough time to negotiate a bipartisan budget deal that raises the Defense and non-Defense (NDD) spending caps. If the budget deal (#RaisetheCaps) is finalized by the 22nd, Congress may well pass yet another short-term CR to allow a month or two to complete an FY18 omnibus spending bill based on the new, higher funding levels. Continued momentum behind a budget deal is definitely good news, but momentum can wane; here is a new resource, culled from our state-by-state fact sheet series, that...

Pages